Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes. Fetzer DT. AJR Am J Roentgenol 2022;218:761.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fetzer DT. Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes. AJR Am J Roentgenol 2022;218:761.
PMID: 35576533